Is Solesence, Inc. Common Stock (SLSN) overvalued? · rev $62.1M
Solesence, Inc. Common Stock (SLSN) is a household & personal products company listed on US.
This page asks whether Solesence, Inc. Common Stock (SLSN) looks expensive on cached numbers — not a short thesis.
Latest reported SLSN revenue for 2025-12-31 was $62.1M. Net income was $1.8M. Revenue was up 18.6% from 2024-12-31 to 2025-12-31. SLSN currently screens at market cap $0.
SLSN currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SLSN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SLSN stock page for the full model, not this heading.
Not investment advice.